References
Original article
Calle, R. A. et al. ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials. Nat. Med. https://doi.org/10.1038/s41591-021-01489-1 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greenhill, C. Phase IIa results for potential NAFLD therapy. Nat Rev Endocrinol 18, 2 (2022). https://doi.org/10.1038/s41574-021-00590-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-021-00590-2
- Springer Nature Limited